FILE:LH/LH-8K-20030224170036.txt.gz
EVENTS:	
TEXT:
ITEM: 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 24, 2003 - ------------------ (Date of earliest event reported) LABORATORY CORPORATION OF AMERICA HOLDINGS - ------------------------------------------ (Exact name of registrant as specified in its charter) DELAWARE 1-11353 13-3757370 -------------- ----------- -------------- (State or other (Commission (IRS Employer jurisdiction of File Number) Identification incorporation) Number) 358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA 27215 - ------------------------------------------------------- (Address of principal executive offices) 336-229-1127 - ------------ (Registrant's telephone number, including area code) ITEM 9. Regulation FD Disclosure This 8-K/A amends the Form 8-K which was furnished on February 18, 2003 to correct the EPS amounts for December 31, 2001. Exhibits: 99.1 Amended Consolidated Statements of Operations. SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LABORATORY CORPORATION OF AMERICA HOLDINGS ------------------------------------------ (Registrant) By:/s/ BRADFORD T. SMITH ---------------------------------- Bradford T. Smith Executive Vice President and Secretary Date: February 24, 2003

EXHIBIT 99.1 LABORATORY CORPORATION OF AMERICA HOLDINGS Consolidated Statements of Operations (in millions, except per share data) Year Ended December 31, --------------------- 2002 2001 --------------------- Net sales $2,507.7 $2,199.8 Cost of sales 1,445.9 1,274.2 Selling, general and administrative 585.5 516.5 Amortization of intangibles and other assets 23.8 41.5 Restructuring and other special charges 17.5 -- ------- ------- Operating income 435.0 367.6 ------- ------- Other income (expense) (0.6) (1.8) Interest income 3.7 2.4 Interest expense (19.2) (27.0) Income from equity investments, net 13.4 -- Termination of interest rate swap agreement -- (8.9) ------- ------- Earnings before income taxes and extraordinary loss 432.3 332.3 Provision for income taxes 177.7 149.5 ------- ------- Net earnings before extraordinary loss $ 254.6 $ 182.8 Extraordinary loss, net of tax benefit -- 3.2 ------- ------- Net earnings after extraordinary loss $ 254.6 $ 179.6 ======= ======= Net earnings before extraordinary loss and special charges $ 264.8 $ 187.7 ======= ======= Diluted earnings per common share: - --------------------------------- Net earnings before extraordinary loss $ 1.77 $ 1.29 ------- ------- Net earnings after extraordinary loss $ 1.77 $ 1.27 ------- ------- Net earnings before extraordinary loss and special charges $ 1.84 $ 1.33 ------- ------- Weighted average shares oustanding 144.2 141.1 ------- ------- EBITDA $ 563.8 $ 468.7 ------- -------


